• FirefoxInstall the new Firefox »
  •  Dow Up 0.50% Nasdaq Up 0.52%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.40 Down 0.11(2.44%) 10:06AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.51
    Open:4.44
    Bid:4.43 x 2800
    Ask:4.44 x 7100
    1y Target Est:7.58
    Beta:-4.12
    Next Earnings Date: 2-Mar-15ARNA Earnings announcement
    Day's Range:4.40 - 4.51
    52wk Range:3.26 - 7.24
    Volume:675,002
    Avg Vol (3m):8,292,680
    Market Cap:968.50M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 2.44%968.50M
    GSKUp 0.19%114.29B
    OREX 0.00%696.31M
    RHHBYDown 0.06%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.25
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.94

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback